Skip to main content

Botox News (Page 2)

FDA Approves Botox to Treat Chronic Migraine

SILVER SPRING, Md., Oct. 15 – The U.S. Food and Drug Administration today approved Botox injection (onabotulinumtoxinA) to prevent headaches in adult patients with chronic migraine. Chronic migraine...

Botox (onabotulinumtoxinA) Receives FDA Approval for Treatment of Upper Limb Spasticity in Adults

IRVINE, Calif.--(BUSINESS WIRE)--Mar 10, 2010 - Allergan, Inc. today announced that the United States Food and Drug Administration (FDA) has approved Botox (onabotulinumtoxinA) for the treatment of...

FDA Medwatch Alert: Botox and Botox Cosmetic (Botulinum toxin Type A) and Myobloc (Botulinum toxin Type B)

FDA notified healthcare professionals that after an ongoing safety review initiated in February 2008, the manufacturers of licensed botulinum toxin products will be required by FDA to strengthen...

FDA Medwatch Alert: Botox, Botox Cosmetic (Botulinum toxin Type A), Myobloc (Botulinum toxin Type B)

[Posted 02/07/2008] FDA issued an early communication about an ongoing safety review regarding Botox and Botox Cosmetic. FDA has received reports of systemic adverse reactions including respiratory...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Chronic Migraine, Facial Wrinkles, Hyperhidrosis, Migraine Prevention, Migraine Prophylaxis, Overactive Bladder, Urinary Incontinence

Botox patient information at Drugs.com